Literature DB >> 10457536

Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression.

G Juckel1, A Mendlin, B L Jacobs.   

Abstract

Decreased activity of the prefrontal cortex (PFC), as well as reduced serotonergic neurotransmission, is considered as a characteristic feature of major depression. The mechanism by which electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) achieve their antidepressant effects may involve changes in PFC activity. It is, however, still unclear whether these changes are accompanied by increased synaptic availability of serotonin (5-HT). In the present study, 5-HT efflux in the rat ventral hippocampus and amygdala was analyzed using in vivo microdialysis during low-current electrical stimulation of PFC and other cortical regions. Electrical stimulation of the medial PFC produced current-dependent increases in limbic 5-HT output in both urethane-anesthetized and behaving rats. No effects on 5-HT levels were seen after comparable stimulation of either the lateral parts of the PFC, the medial precentral area, the primary motor cortex or the parietal cortex. This pronounced regional specificity of the effect of medial PFC stimulation on limbic 5-HT output suggests that activation of this particular area might play a crucial role in such antidepressant treatments as ECT and TMS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457536     DOI: 10.1016/S0893-133X(98)00097-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  24 in total

Review 1.  [Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].

Authors:  Andreas Heinz; Dieter F Braus; Berenice Romero; Jürgen Gallinat; Imke Puls; Georg Juckel; Daniel R Weinberger
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

Review 2.  Preclinical studies modeling deep brain stimulation for depression.

Authors:  Clement Hamani; José N Nobrega
Journal:  Biol Psychiatry       Date:  2012-06-29       Impact factor: 13.382

3.  Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry.

Authors:  John P O'Reardon; Andrew D Peshek; Rocio Romero; Pilar Cristancho
Journal:  Psychiatry (Edgmont)       Date:  2006-01

4.  Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex.

Authors:  Francis Rodriguez Bambico; Noam Katz; Guy Debonnel; Gabriella Gobbi
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

5.  Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime alcohol dependence.

Authors:  Leo Sher; Matthew S Milak; Ramin V Parsey; Juan J Carballo; Thomas B Cooper; Kevin M Malone; Maria A Oquendo; J John Mann
Journal:  Eur Neuropsychopharmacol       Date:  2007-05-02       Impact factor: 4.600

6.  Determination of zeta-potential in rat organotypic hippocampal cultures.

Authors:  Yifat Guy; Mats Sandberg; Stephen G Weber
Journal:  Biophys J       Date:  2008-02-08       Impact factor: 4.033

7.  Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway.

Authors:  Jing-Jie Yu; Yong Zhang; Ying Wang; Zi-Yu Wen; Xiao-Hua Liu; Jing Qin; Jian-Li Yang
Journal:  Psychopharmacology (Berl)       Date:  2012-08-09       Impact factor: 4.530

8.  Serotonergic modulation of orbitofrontal activity and its relevance for decision making and impulsivity.

Authors:  Paraskevi Mavrogiorgou; Björn Enzi; Ann-Kristin Klimm; Elke Köhler; Patrik Roser; Christine Norra; Georg Juckel
Journal:  Hum Brain Mapp       Date:  2016-11-11       Impact factor: 5.038

9.  Network-Guided Transcranial Magnetic Stimulation for Depression.

Authors:  Marc J Dubin; Conor Liston; Michael A Avissar; Irena Ilieva; Faith M Gunning
Journal:  Curr Behav Neurosci Rep       Date:  2017-02-07

10.  Prelimbic Cortical Injections of a GABA Agonist and Antagonist: In Vivo Quantification of the Effect in the Rat Brain Using [(18)F] FDG MicroPET.

Authors:  Joke Parthoens; Stijn Servaes; Jeroen Verhaeghe; Sigrid Stroobants; Steven Staelens
Journal:  Mol Imaging Biol       Date:  2015-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.